Cord blood CD34+ cells cultured with FLT3L, stem cell factor, interleukin-6, and IL-3 produce CD11c+CD1a-/c- myeloid dendritic cells

Stem Cells and Development

Volumn 16, Issue 5, 2007, Pages 849-855

  Fadilah, S A W ^a   Vuckovic, S ^b   Khalil, D ^b   Hart, D N J ^b  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; FLT3 LIGAND; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 6; PROSTAGLANDIN E2; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DEVELOPMENTAL STAGE; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LYMPHOCYTE PROLIFERATION; MONOCYTE; MYELOID PROGENITOR CELL; PRIORITY JOURNAL; SURFACE PROPERTY; T LYMPHOCYTE; UMBILICAL CORD BLOOD; UPREGULATION;

ANTIGENS, CD1; ANTIGENS, CD11C; ANTIGENS, CD34; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; FETAL BLOOD; HUMANS; INTERLEUKIN-3; INTERLEUKIN-6; INTERLEUKINS; MEMBRANE PROTEINS; MYELOID CELLS; PHENOTYPE; STEM CELL FACTOR; STEM CELLS; T-LYMPHOCYTES;

EID: 36248974252     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0003     Document Type: Article

References (29)

1. Luznik L and EJ Fuchs. (2002). Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation. Cancer Control 9:123-137.
2. Reddy P, Y Maeda, C Liu et al. (2005). A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nature Med 11:1244-1249.
3. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med 184:695-706.
4. Rosenzwajg M, B Canque and JC Gluckman. (1996). Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells. Blood 87:535-544.
5. Szabolcs P, D Avigan, S Gezelter et al. (1996). Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood 87:4520-4530.
6. Arrighi JF, C Hauser, B Chapuis et al. (1999). Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-)CD14(-) and a CD34(-) CD14(+) dendritic cell precursor. Blood 93:2244-2252.
7. Bontkes HJ, TD De Gruijl, GJ Schuurhuis et al. (2002). Expansion of dendritic cell precursors from human CD34(+) progenitor cells isolated from healthy donor blood; growth factor combination determines proliferation rate and functional outcome. J Leukoc Biol 72:321-329.
8. Encabo A, P Solves, E Mateu et al. (2004). Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3. Stem Cells 22:725-740.
9. Herbst B, G Kohler, A Mackensen et al. (1996). In vitro differentiation of CD34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the birbeck granule and MIIC-positive Langerhans cell and the interdigitating dendritic cell type. Blood 88:2541-2548.
10. Dzionek A, A Fuchs, P Schmidt et al. (2000). BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 165:6037-6046.
11. MacDonald KPA, D Munster, G Clark et al. (2000). Peripheral blood dendritic cell subset analysis. In: Leucocyte Typing VII. D Mason, ed. Oxford University Press, Oxford.
12. Shortman K and YJ Liu. (2002). Mouse and human dendritic cell subtypes. Nature Rev Immunol 2:151-161.
13. Vuckovic S, GJ Clark and DNJ Hart. (2002). Growth factors, cytokines and dendritic cell development. In: Current Pharmacutical Design. K Bradstock, ed. Vol. 8. Bentham Science Publishers, Ltd., Karachi, Pakistan, pp. 125-133
14. Lau J, M Sartor, KF Bradstock et al. (2007). Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease. Transplantation 83:839-846.
15. Radford KJ, CJ Turtle, AJ Kassianos et al. (2005). Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy. J Immunother 28:322-331.
16. Majhail NS, CG Brunstein and JE Wagner. (2006). Double umbilical cord blood transplantation. Curr Opin Immunol 18:571-575.
17. Monji T, J Petersons, NK Saund et al. (2002). Competent dendritic cells derived from CD34+ progenitors express CMRF-44 antigen early in the differentiation pathway. Immunol Cell Biol 80:216-225.
18. Vuckovic S, D Gardiner, K Field et al. (2004). Monitoring dendritic cells in clinical practice using a new whole blood single-platform TruCOUNT assay. J Immunol Methods 284:73-87.
19. Osugi Y, S Vuckovic and DN Hart. (2002). Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood 100:2858-2866.
20. Lindstedt M, K Lundberg and CA Borrebaeck. (2005). Gene family clustering identifies functionally associated subsets of human in vivo blood and tonsillar dendritic cells. J Immunol 175:4839-4846.
21. Radford KJ, CJ Turtle, AJ Kassianos et al. (2006). CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression. J Immunother 29:596-605.
22. Nestle FO, J Banchereau and D Hart. (2001). Dendritic cells: on the move from bench to bedside. Nature Med 7:761-765.
23. Grouard G, MC Rissoan, L Filgueira et al. (1997). The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 185:1101-1111.
24. Blom B, S Ho, S Antonenko et al. (2000). Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells. J Exp Med 192:1785-1796.
25. Spits H, F Couwenberg, AQ Bakker et al. (2000). Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J Exp Med 192:1775-1784.
26. Galy A, M Travis, D Cen et al. (1995). Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3:459-473.
27. de Vries IJ, AA Eggert, NM Scharenborg et al. (2002). Phenotypical and functional characterization of clinical grade dendritic cells. J Immunother 25:429-438.
28. De Vries IJ, DJ Krooshoop, NM Scharenborg et al. (2003). Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res 63:12-17.
29. Hsu AK, BM Kerr, KL Jones et al. (2006). RNA loading of leukemic antigens into cord blood-derived dendritic cells for immunotherapy. Biol Blood Marrow Transplant 12: 855-867.